Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open-label, Prospective, Controlled Clinical Trial on Effects and Safety of Adrenal Artery Ablation (Triple A) for Primary Aldosteronism

NCT03398785 is registered in ClinicalTrials.gov with Third Military Medical University as lead sponsor.

NCT NCT03398785
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03398785 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open-label, Prospective, Controlled Clinical Trial on Effects and Safety of Adrenal Artery Ablation (Triple A) for Primary Aldosteronism
Lead sponsor
Third Military Medical University
Phase
Phase 3
Overall status
Completed
Start date
October 1, 2017
Completion date
June 30, 2019
Enrollment
66 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hypertension, primary aldosteronism